The treatment of acute promyelocytic leukemia is broadly divided into anti-leukemia therapies and supportive therapies. Anti-leukemia therapies function to eliminate cancer cells, whereas supportive therapies are temporizing measures that can control the disease for a short time until anti-leukemic therapy takes effect. Anti-leukemic therapies include all-trans retinoic acid, arsenic trioxide, gemtuzumab ozogamicin, and cytarabine. Supportive therapies include transfusions (such as cryoprecipitate or platelet transfusions) and granulocyte colony stimulating factor.
Acute promyelocytic leukemia medical therapy
Acute myeloid leukemia medical therapy
Acute promyelocytic leukemia medical Interventions
Acute lymphoblastic leukemia medical therapy
Myeloproliferative neoplasm medical therapy
Myelodysplastic syndrome medical therapy
Hairy cell leukemia medical therapy
Chronic myelogenous leukemia medical therapy